Enzymology and Fungal Biotechnology Lab., Botany and Microbiology Department, Faculty of Science, Zagazig University, Zagazig 44519, Egypt.
Limnology Department, Central Laboratory of Aquaculture Research, Tell El Kebir 41626, Egypt.
Molecules. 2021 Mar 1;26(5):1309. doi: 10.3390/molecules26051309.
Tyrosinase is a copper-containing monooxygenase catalyzing the -hydroxylation of tyrosine to 3,4-dihydroxyphenylalanine then to dopaquinone that is profoundly involved in melanin synthesis in eukaryotes. Overactivation of tyrosinase is correlated with hyperpigmentation that is metabolically correlated with severe pathological disorders, so, inhibition of this enzyme is the most effective approach in controlling the overproduction of melanin and its hazardous effects. Thus, searching for a powerful, selective inhibitor of human tyrosinase to limit the hyper-synthesis of melanin is a challenge. Unlike the difficulty of overexpression of human tyrosinase, using fungal tyrosinase as a model enzyme to the human one to evaluate the mechanistics of enzyme inhibition in response to various compounds is the most feasible strategy. Thus, the purification of highly catalytic-efficient fungal tyrosinase, exploring a novel inhibitor, and evaluating the mechanistics of enzyme inhibition are the main objectives of this work. and were reported as the most potential tyrosinase producers. The biochemical properties suggest that this enzyme displays a higher structural and catalytic proximity to human tyrosinase. Upon nutritional bioprocessing by Plackett-Burman design, the yield of tyrosinase was increased by about 7.5-folds, compared to the control. The purified tyrosinase was strongly inhibited by kojic acid and DCM extracts with IC values of 15.1 and 12.6 µg/mL, respectively. From the spectroscopic analysis, the main anti-tyrosinase compounds of extract was resolved, and verified as undecanoic acid. Further studies are ongoing to unravel the in vivo effect and cytotoxicity of this compound in fungi and human, that could be a novel drug to various diseases associated with hyperpigmentation by melanin.
酪氨酸酶是一种含铜的单加氧酶,可催化酪氨酸的 -羟化生成 3,4-二羟基苯丙氨酸,然后生成多巴醌,该酶在真核生物的黑色素合成中起着至关重要的作用。酪氨酸酶的过度激活与过度色素沉着有关,而后者与严重的病理紊乱有关,因此,抑制这种酶是控制黑色素过度产生及其有害影响的最有效方法。因此,寻找一种强大、选择性的人酪氨酸酶抑制剂来限制黑色素的过度合成是一项挑战。与过表达人酪氨酸酶的困难不同,使用真菌酪氨酸酶作为模型酶来评估对各种化合物的酶抑制机制是最可行的策略。因此,本工作的主要目标是纯化高效催化的真菌酪氨酸酶、探索新型抑制剂,并评估酶抑制的机制。黑曲霉和米根霉被报道为最有潜力的酪氨酸酶产生菌。生化特性表明,该酶与人类酪氨酸酶在结构和催化上更为接近。通过 Plackett-Burman 设计的营养生物加工,与对照相比,酪氨酸酶的产量增加了约 7.5 倍。纯化的酪氨酸酶被曲酸和 DCM 提取物强烈抑制,IC 值分别为 15.1 和 12.6 µg/mL。从光谱分析中,解析并验证了提取物中主要的抗酪氨酸酶化合物为十一烷酸。正在进行进一步的研究以揭示该化合物在真菌和人体中的体内作用和细胞毒性,它可能成为治疗与黑色素过度沉着相关的各种疾病的一种新型药物。